» Articles » PMID: 31891018

A Novel Enhancer RNA, Hmrhl, Positively Regulates Its Host Gene, in Chronic Myelogenous Leukemia

Overview
Date 2020 Jan 1
PMID 31891018
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Noncoding RNAs are increasingly being accredited with key roles in gene regulation during development and disease. Here we report the discovery and characterization of a novel long noncoding RNA, Hmrhl, which shares synteny and partial sequence similarity with the mouse lncRNA, Mrhl. The human homolog, Hmrhl, transcribed from intron 14 of gene, is 5.5 kb in size, expressed in all tissues examined and is associated with chromatin. Analysis of Hmrhl locus using ENCODE database revealed that it exhibits hallmarks of enhancers like the open chromatin configuration, binding of transcription factors, enhancer specific histone signature etc. in the K562 Chronic Myelogenous Leukemia (CML) cells. We compared the expression of Hmrhl in the normal lymphoblast cell line, GM12878, with that of K562 cells and lymphoma samples and show that it is highly upregulated in leukemia as well as several cases of lymphoma. Further, we validated the enhancer properties of Hmrhl locus in K562 cells with the help of ChIP-qPCR and Luciferase assay. Moreover, siRNA mediated down-regulation of Hmrhl in K562 cells leads to a concomitant down regulation of its parent gene, , showing that Hmrhl functions as an enhancer RNA and positively regulates its host gene, in chronic myelogenous leukemia. This study is significant in view of the fact that a better understanding of mechanism of gene regulation under normal conditions and its perturbation in cancer could in turn help in its therapeutic intervention through molecular medicine/RNA based drug discovery.

Citing Articles

SCAR-6 elncRNA locus epigenetically regulates PROZ and modulates coagulation and vascular function.

Ranjan G, Sehgal P, Scaria V, Sivasubbu S EMBO Rep. 2024; 25(11):4950-4978.

PMID: 39358551 PMC: 11549340. DOI: 10.1038/s44319-024-00272-w.


Identification of PAX6 and NFAT4 as the Transcriptional Regulators of the Long Noncoding RNA Mrhl in Neuronal Progenitors.

Pal D, Dutta S, Iyer D, Shriram D, Bhaduri U, Rao M Mol Cell Biol. 2022; 42(11):e0003622.

PMID: 36317923 PMC: 9670966. DOI: 10.1128/mcb.00036-22.


Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects.

Wan L, Li W, Meng Y, Hou Y, Chen M, Xu B Front Immunol. 2022; 13:849451.

PMID: 35514959 PMC: 9063412. DOI: 10.3389/fimmu.2022.849451.


LncRNA Hmrhl regulates expression of cancer related genes in chronic myelogenous leukemia through chromatin association.

Choudhury S, Dutta S, Bhaduri U, Satyanarayana Rao M NAR Cancer. 2021; 3(4):zcab042.

PMID: 34734184 PMC: 8559160. DOI: 10.1093/narcan/zcab042.


m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression miR-766-5p/CDKN1A Axis.

Yao F, Zhao C, Zhong F, Qin T, Wen F, Li M Front Oncol. 2021; 11:679634.

PMID: 34354942 PMC: 8329653. DOI: 10.3389/fonc.2021.679634.


References
1.
Ong C, Corces V . Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 2011; 12(4):283-93. PMC: 3175006. DOI: 10.1038/nrg2957. View

2.
Sangle N, Perkins S . Core-binding factor acute myeloid leukemia. Arch Pathol Lab Med. 2011; 135(11):1504-9. DOI: 10.5858/arpa.2010-0482-RS. View

3.
De Villiers J, Schaffner W . A small segment of polyoma virus DNA enhances the expression of a cloned beta-globin gene over a distance of 1400 base pairs. Nucleic Acids Res. 1981; 9(23):6251-64. PMC: 327601. DOI: 10.1093/nar/9.23.6251. View

4.
Lam M, Li W, Rosenfeld M, Glass C . Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci. 2014; 39(4):170-82. PMC: 4266492. DOI: 10.1016/j.tibs.2014.02.007. View

5.
Hah N, Murakami S, Nagari A, Danko C, Kraus W . Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013; 23(8):1210-23. PMC: 3730096. DOI: 10.1101/gr.152306.112. View